Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

ClinicalTrials.gov ID: NCT05259033

Public ClinicalTrials.gov record NCT05259033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52 Week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Once Weekly Semaglutide, Both Treatment Arms With or Without Oral Anti Diabetic Drugs, in Participants With Type 2 Diabetes Inadequately Controlled With a GLP 1 Receptor Agonist. COMBINE 2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to semaglutide taken once a week in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar level in people with type 2 diabetes compared to semaglutide. Participants will either get IcoSema or semaglutide. Which treatment participants get is decided by chance. IcoSema is a new medicine that doctors cannot prescribe. Doctors can already prescribe semaglutide in many countries. Participants will get IcoSema or semaglutide, which they must inject once a week with a pen, which has a small needle, in a skin fold in the thigh, upper arm, or stomach. The study will last for about 1 year and 1 month. Participants will have 18 clinic visits, 34 phone/video calls with the study doctor, and 4 contacts with the site that can either be clinic visits or phone/video calls. At 11 clinic visits participants will have blood samples taken. At 7 clinic visits participants cannot eat or drink (except for water) for 8 hours before the visit. Women cannot take part if pregnant, breast-feeding or plan to get pregnant during the study period.

Study identification

NCT ID
NCT05259033
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
683 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2022 (Actual)
Primary completion
Dec 13, 2023 (Actual)
Completion
Jan 16, 2024 (Actual)
Last update posted
Jun 12, 2026

2022 – 2024

United States locations

U.S. sites
76
U.S. states
30
U.S. cities
68
Facility City State ZIP Site status
Univ of AL at Birmingham_BRM Birmingham Alabama 35294 —
Pri Med Grp dba/Gil Ctr Fam Gilbert Arizona 85296 —
Phoenician Centers for Research & Innovation PCRI Phoenix Arizona 85021 —
Clinical Research Institute of Arizona Sun City West Arizona 85375 —
John Muir Physicians Network Concord California 94520 —
Scripps Whittier Diabetes Inst La Jolla California 92037 —
Clinical Trials Research_Sacramento Lincoln California 95821 —
Downtown LA Res Ctr. Inc. Los Angeles California 90017 —
Velocity Clin Res Los Angeles Los Angeles California 90017 —
Velocity Clin Res Wstlke Los Angeles California 90057 —
Valley Clinical Trials, Inc. Northridge California 91325 —
San Diego Family Care_San Diego San Diego California 92111 —
Premier Medical Center, Inc. Toluca Lake California 91602 —
Northeast Research Institute Fleming Island Florida 32003 —
Encore Medical Research LLC Hollywood Florida 33024 —
Northeast Res Inst. Inc. Jacksonville Florida 32204 —
Est Cst Inst for Rsrch,Jksnvil Jacksonville Florida 32216 —
University Of Miami Miami Florida 33136 —
South Broward Research LLC Miramar Florida 33027 —
Adult Medicine of Lake County, Inc. Mt. Dora Florida 32757 —
Clinical Neuroscience Solution Orlando Florida 32801 —
Florida Institute For Clinical Research Orlando Florida 32825 —
Oviedo Medical Research, LLC Oviedo Florida 32765 —
Metabolic Research Institute Inc West Palm Beach Florida 33401 —
Javara/Privia Med Grp GA,LLC Albany Georgia 31707 —
Endo Res Solutions Inc Roswell Georgia 30076 —
East West Med Res Inst Honolulu Hawaii 96814 —
Saltzer Medical Group Research Nampa Idaho 83686-6011 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
Macoupin Research Group Gillespie Illinois 62033 —
Endeavor Health Skokie Illinois 60077 —
Central Illinois Diabetes and Clinical Research Springfield Illinois 62711 —
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383 —
Iowa Diab & Endo Res Center West Des Moines Iowa 50266 —
Cotton-O'Neil Diab & Endo Ctr Topeka Kansas 66606 —
L-MARC Research Center Louisville Kentucky 40213 —
Four Rivers Clinical Research Inc Paducah Kentucky 42001 —
Ileana J Tandron APMC Slidell Louisiana 70461-4231 —
MedStar Hlth Res Institute Hyattsville Maryland 20782 —
ActivMed Practice & Research LLC Methuen Massachusetts 01844 —
Northern Pines Hlth Ctr, PC Buckley Michigan 49620 —
Univ of Nebraska Medical CTR Omaha Nebraska 68198-3020 —
Palm Research Center Inc-Vegas Las Vegas Nevada 89148 —
Southern New Hampshire Diabete Nashua New Hampshire 03060 —
John J Shelmet, MD Lawrenceville New Jersey 08648 —
Albuquerque Clin Trials, Inc. Albuquerque New Mexico 87102 —
Endocrine Associates of Long Island, PC Smithtown New York 11787 —
Southgate Medical Group, LLP West Seneca New York 14224 —
PharmQuest Life Sciences LLC Greensboro North Carolina 27408 —
Accellacare Wilmington North Carolina 28401 —
Diab & Endo Assoc of Stark Co Canton Ohio 44718 —
New Venture Medical Research Wadsworth Ohio 44281 —
Thomas Jefferson Univ Di Rsrch Ctr Philadelphia Pennsylvania 19107 —
Hillcrest Clinical Research Simpsonville South Carolina 29681-1538 —
Palmetto Clinical Research Summerville South Carolina 29485 —
AM Diabetes And Endocrinology Center Bartlett Tennessee 38133 —
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404 —
Amarillo Med Spec LLP Amarillo Texas 79106 —
Texas Diab & Endo, P.A. Austin Texas 78731 —
Texas Diabetes & Endocrinology Austin Texas 78749 —
Osvaldo A. Brusco MD Corpus Christi Texas 78414 —
Cedar Research Dallas Texas 75038 —
North Texas Endocrine Center Dallas Texas 75231 —
UT Southwestern Med Cntr Dallas Texas 75390-9302 —
Diabetes and Thyroid Ctr of FW Fort Worth Texas 76132 —
PrimeCare Medical Group Houston Texas 77024 —
DCOL Ctr for Clin Res Longview Texas 75605 —
Texas Diabetes & Endocrinology_Round Rock Round Rock Texas 78681 —
NE Clin Res of San Antonio San Antonio Texas 78233 —
Sugar Lakes Family Practice PA Sugar Land Texas 77479 —
Hillcrest Family Health Center Waco Texas 76710 —
Wade Family Medicine Bountiful Utah 84010 —
Chrysalis Clinical Research St. George Utah 84790 —
Javara Inc. / Privia Medical Group LLC_Forest Forest Virginia 24551 —
Javara Inc/Privia Md GpLLC Fst Forest Virginia 24551 —
TPMG Clinical Research Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05259033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05259033 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →